What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

Cipla | NYPOZI® (filgrastim-txid) Injection

Cipla | NYPOZI® (filgrastim-txid) Injection

300 mcg/0.5mL | 480 mcg/0.8mL

Learn more about Nypozi®

Medical Information:

  • Report Adverse Events/Side Effects
  • Report Product Complaints
  • Submit Medical Inquiries:

Contact Tanvex BioPharma USA at 1-833-826-8398.
You may report side effects to Tanvex BioPharma USA at 1-833-826-8398 or to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Cipla

Cipla News & Announcements

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from Cipla | NYPOZI® (filgrastim-txid) Injection

Name
Address
Subscribe